This $288 Billion Healthcare Market is Expected to Triple by 2030

The U.S. healthcare system has been broken for some time.

In fact, according to 70% of U.S. adults, as noted by Time, the health care system is failing to meet their needs in at least one way.

High costs, ridiculous wait times, poor communication, a severe lack of personalized care, and the impersonal nature of the system is a concern for many, with millions of patients feeling more like a number than a real person.

Most of us are exhausted from it. And we need for it to change.

Not helping, multi-billion-dollar pharmaceutical companies have been exerting considerable influence over the U.S. FDA, raising concerns the agency is putting pharmaceutical company profits and needs well ahead of patients.

As a result, most Americans – like you and I — are fed up. And rightfully so.

But as Bob Dylan once sang, “the times they are a-changin’.”

Helping, Health and Human Services Secretary Robert F. Kennedy Jr. is not only transforming U.S. health policy, he’s also restructuring the focus of some regulators and researchers, and reshaping the mission of his department to focus more on alternative medicine.

Plus, more Americans are also far more proactive about their health, looking for ways to maintain their well-being, leading to their willingness to consider supplements.

We’re also seeing substantial demand for self-care digital platforms, fueled by health awareness, convenience, personalization, and cost-savings issues. Also, with more Americans now far more proactive about their health, they’re looking for ways to feel and look good, with digital platforms offering quick, convenient information.

In short, a major  health revolution  is now underway in North America.

With it, the digital health market is absolutely exploding, with experts projecting that the current $288 billion industry will  more than triple in size  by 2030.

As more people seek out smarter, faster and more personalized care – available in many cases right on their smartphone – they’re using technology to take control of their health choices.

That’s where companies like PanGenomic Health (CSE: NARA) come into play.

PanGenomic Health  is developing an intelligent, AI-powered wellness ecosystem designed to help users take control of their physical and mental well-being with precision treatments rooted in natural medicine, genomics and diagnostic insights.

In fact, the company’s Nara.ai platform is allowing users to leverage artificial intelligence to help them achieve personal well-being, and help them treat specific ailments on their own.

Nara is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. With personalized insights and evidence-backed resources, users can take back control of their mental health.

The Nara.AI platform will leverage the NARA app and Mujn diagnostic tools to make recommendation information available for the user or their health practitioner about personalized alternative health treatments, including initial dosages and dose changes from ongoing monitoring.

It’s essentially putting a personal health coach in your back pocket.

Again, that’s substantial news for companies, like PanGenomic Health, which has positioned itself to monetize multiple parts of the consumer’s wellness journey:

• E-commerce:  PanGenomic Health’s  largest future revenue stream will come from its AI-powered product recommendation engine. As users shop for supplements, peptides and wellness solutions, PanGenomic receives a portion of every transaction.
• App Subscriptions:  Users pay to unlock advanced tools inside the NARA app, such as ongoing tracking, deeper insights and premium guidance.
• Diagnostic Tools:  Through MUJN,  PanGenomic  Health  will generate revenue by offering subscription and per-use pricing on its biomarker tracking hits.

Even better, the company is developing a new AI health platform for personalized alternative health products”, said Maryam Marissen, President & CEO of PanGenomic Health.

“Consumers and their health practitioners face challenges in understanding which alternative health products are right for the whole health of an individual, and we believe that our NaraCare.AI platform can become the trusted source for consumers and practitioners across North America.”

With a market cap of just roughly $2 million CAD,  PanGenomic  is still trading at a valuation well below its peers, and offers significant upside potential for investors.